QTRX (STOCKS)
Quanterix Corporation Common Stock
$5.980000
-0.140000 (-2.29%)
Prev close: $6.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Everett V. Cunningham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $281.18M
- Employees
- 136
- P/E (TTM)
- -2.57
- P/B (TTM)
- 0.89
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
6
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.73 | $-0.54 | -0.1894 | -35.04% |
|
Jun 2025 (Q2)
|
$-0.57 | $-0.37 | -0.2028 | -55.23% |
|
Mar 2025 (Q1)
|
$-0.42 | $-0.45 | +0.0254 | +5.70% |
|
Dec 2024 (Q4)
|
$-0.30 | $-0.26 | -0.0399 | -15.34% |
Financial Statements
| Revenues | $130.20M |
| Benefits Costs and Expenses | $231.34M |
| Cost Of Revenue | $63.11M |
| Costs And Expenses | $231.34M |
| Gross Profit | $67.09M |
| Operating Expenses | $182.65M |
| Selling, General, and Administrative Expenses | $131.47M |
| Research and Development | $35.19M |
| Other Operating Expenses | $15.99M |
| Operating Income/Loss | -$115.56M |
| Income/Loss From Continuing Operations After Tax | -$95.66M |
| Income/Loss From Continuing Operations Before Tax | -$101.14M |
| Income Tax Expense/Benefit | -$5.47M |
| Interest Income/Expense After Provision For Losses | $10.74M |
| Interest Income/Expense Operating, Net | $10.90M |
| Net Income/Loss | -$95.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$95.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$95.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $154.00K |
| Basic Earnings Per Share | -$2.33 |
| Diluted Earnings Per Share | -$2.33 |
| Basic Average Shares | 123,733,000 |
| Diluted Average Shares | 123,733,000 |
| Assets | $444.14M |
| Current Assets | $233.28M |
| Inventory | $54.96M |
| Other Current Assets | $178.32M |
| Noncurrent Assets | $210.86M |
| Fixed Assets | $25.77M |
| Intangible Assets | $135.15M |
| Other Non-current Assets | $49.95M |
| Liabilities | $129.61M |
| Current Liabilities | $77.35M |
| Accounts Payable | $10.63M |
| Other Current Liabilities | $66.72M |
| Noncurrent Liabilities | $52.25M |
| Equity | $314.53M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $314.53M |
| Liabilities And Equity | $444.14M |
| Net Cash Flow From Operating Activities | -$65.09M |
| Net Cash Flow From Operating Activities, Continuing | -$65.09M |
| Net Cash Flow From Investing Activities | $74.18M |
| Net Cash Flow From Investing Activities, Continuing | $74.18M |
| Net Cash Flow From Financing Activities | -$145.00K |
| Net Cash Flow From Financing Activities, Continuing | -$145.00K |
| Exchange Gains/Losses | $749.00K |
| Net Cash Flow | $9.69M |
| Net Cash Flow, Continuing | $8.94M |
| Comprehensive Income/Loss | -$95.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$95.07M |
| Other Comprehensive Income/Loss | $593.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $593.00K |